JP2005537027A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005537027A5 JP2005537027A5 JP2004535871A JP2004535871A JP2005537027A5 JP 2005537027 A5 JP2005537027 A5 JP 2005537027A5 JP 2004535871 A JP2004535871 A JP 2004535871A JP 2004535871 A JP2004535871 A JP 2004535871A JP 2005537027 A5 JP2005537027 A5 JP 2005537027A5
- Authority
- JP
- Japan
- Prior art keywords
- ovarian endometriosis
- related gene
- oex
- compound
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000002595 endometriosis of ovary Diseases 0.000 claims description 38
- 208000030747 ovarian endometriosis Diseases 0.000 claims description 38
- 108090000623 proteins and genes Proteins 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 21
- 229920001184 polypeptide Polymers 0.000 claims description 17
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 17
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 17
- 230000004071 biological effect Effects 0.000 claims description 7
- 239000012472 biological sample Substances 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 5
- 206010011732 Cyst Diseases 0.000 claims description 4
- 108020004414 DNA Proteins 0.000 claims description 4
- 208000031513 cyst Diseases 0.000 claims description 4
- 230000002357 endometrial effect Effects 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 238000009396 hybridization Methods 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims 19
- 238000012360 testing method Methods 0.000 claims 12
- 230000000694 effects Effects 0.000 claims 5
- 150000007523 nucleic acids Chemical group 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 4
- 230000007423 decrease Effects 0.000 claims 4
- 210000002919 epithelial cell Anatomy 0.000 claims 4
- 239000000523 sample Substances 0.000 claims 4
- 238000012216 screening Methods 0.000 claims 4
- 108700008625 Reporter Genes Proteins 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 2
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 108020004459 Small interfering RNA Proteins 0.000 claims 1
- 239000000074 antisense oligonucleotide Substances 0.000 claims 1
- 238000012230 antisense oligonucleotides Methods 0.000 claims 1
- 230000027455 binding Effects 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 239000004055 small Interfering RNA Substances 0.000 claims 1
- 230000002103 transcriptional effect Effects 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 244000247617 Teramnus labialis var. labialis Species 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40736502P | 2002-08-30 | 2002-08-30 | |
| US45092003P | 2003-02-28 | 2003-02-28 | |
| PCT/JP2003/010257 WO2004024952A1 (en) | 2002-08-30 | 2003-08-12 | Method of diagnosing ovarian endometriosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009178542A Division JP4942052B2 (ja) | 2002-08-30 | 2009-07-31 | 卵巣子宮内膜症の診断法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005537027A JP2005537027A (ja) | 2005-12-08 |
| JP2005537027A5 true JP2005537027A5 (https=) | 2006-09-21 |
| JP4401295B2 JP4401295B2 (ja) | 2010-01-20 |
Family
ID=31997699
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004535871A Expired - Fee Related JP4401295B2 (ja) | 2002-08-30 | 2003-08-12 | 卵巣子宮内膜症の診断法 |
| JP2009178542A Expired - Fee Related JP4942052B2 (ja) | 2002-08-30 | 2009-07-31 | 卵巣子宮内膜症の診断法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009178542A Expired - Fee Related JP4942052B2 (ja) | 2002-08-30 | 2009-07-31 | 卵巣子宮内膜症の診断法 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1537243B1 (https=) |
| JP (2) | JP4401295B2 (https=) |
| AT (1) | ATE397098T1 (https=) |
| AU (1) | AU2003253440A1 (https=) |
| CA (1) | CA2497132A1 (https=) |
| DE (1) | DE60321356D1 (https=) |
| WO (1) | WO2004024952A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4603548B2 (ja) * | 2003-09-24 | 2010-12-22 | オンコセラピー・サイエンス株式会社 | Ｔｆｐｉ−２タンパク質を用いた卵巣子宮内膜症の診断法 |
| JP2008537474A (ja) * | 2005-02-18 | 2008-09-18 | アメリカ合衆国 | 血液リンパ球における子宮内膜症に関する分子診断マーカーの同定 |
| US11287425B2 (en) | 2009-04-22 | 2022-03-29 | Juneau Biosciences, Llc | Genetic markers associated with endometriosis and use thereof |
| US8932993B1 (en) | 2007-06-11 | 2015-01-13 | Juneau Biosciences, LLC. | Method of testing for endometriosis and treatment therefor |
| EP2065707A1 (en) | 2007-11-28 | 2009-06-03 | Laboratorios S.A.L.V.A.T., S.A. | Detection of endometrial secretion markers for assesment of endometriosis |
| ES2534437T3 (es) | 2008-06-30 | 2015-04-22 | Oncotherapy Science, Inc. | Anticuerpos anti-CDH3 marcados con etiqueta de radioisótopo y usos de los mismos |
| TW201008574A (en) | 2008-08-19 | 2010-03-01 | Oncotherapy Science Inc | INHBB epitope peptides and vaccines containing the same |
| JP5526378B2 (ja) * | 2009-03-05 | 2014-06-18 | 国立大学法人山口大学 | 子宮頸癌の検出方法 |
| WO2011080796A1 (en) | 2009-12-28 | 2011-07-07 | Oncotherapy Science, Inc. | Anti-cdh3 antibodies and uses thereof |
| JP5224308B2 (ja) * | 2010-02-22 | 2013-07-03 | 公立大学法人横浜市立大学 | 卵巣明細胞腺癌に特異的に発現しているタンパク質とその応用 |
| DE102012002929A1 (de) | 2012-02-14 | 2013-08-14 | Jürgen Lewald | Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose |
| US9434991B2 (en) | 2013-03-07 | 2016-09-06 | Juneau Biosciences, LLC. | Method of testing for endometriosis and treatment therefor |
| SG11201700303UA (en) * | 2014-07-17 | 2017-02-27 | Celmatix Inc | Methods and systems for assessing infertility and related pathologies |
| JP6535357B2 (ja) * | 2017-02-06 | 2019-06-26 | 国立研究開発法人農業・食品産業技術総合研究機構 | 非アルコール性脂肪肝治療用組成物、非アルコール性脂肪肝の治療剤の候補物質のスクリーニング方法及びｄｎａチップ |
| CN112470002A (zh) * | 2018-04-20 | 2021-03-09 | 德克萨斯大学体系董事会 | 用于治疗子宫内膜异位症的组合物和方法 |
| CN110408695A (zh) * | 2019-04-05 | 2019-11-05 | 辽宁省肿瘤医院 | 子宫内膜异位症恶变相关卵巢癌诊断或预后标志物及应用 |
| WO2020218465A1 (ja) * | 2019-04-26 | 2020-10-29 | 中外製薬株式会社 | 子宮内膜症の診断方法、病態モニタリング方法及びキット |
| JP2021175394A (ja) * | 2020-04-24 | 2021-11-04 | 花王株式会社 | 月経周期マーカー |
| WO2024223379A1 (en) * | 2023-04-27 | 2024-10-31 | Scailyte Ag | Biomarkers for the diagnosis of diseases or disorders of the female reproductive tract |
| CN119769990B (zh) * | 2024-12-26 | 2025-09-09 | 大连医科大学附属第二医院 | 子宫内膜异位症的检测系统和治疗剂 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0828003A3 (en) * | 1996-09-06 | 2003-01-15 | SmithKline Beecham plc | Human serine protease |
| GB9806104D0 (en) * | 1998-03-20 | 1998-05-20 | Smithkline Beecham Biolog | Novel compounds |
| WO1999052942A2 (en) * | 1998-04-15 | 1999-10-21 | Genset | Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma |
| AU3395900A (en) * | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
| AU2001266787A1 (en) * | 2000-06-07 | 2002-01-08 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
| WO2002000939A2 (en) * | 2000-06-28 | 2002-01-03 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| DE10048633A1 (de) * | 2000-09-25 | 2002-04-18 | Schering Ag | Methode zur in vitro Diagnostik von Endometriose |
| EP1202065A1 (en) * | 2000-10-25 | 2002-05-02 | Aventis Pharma S.A. | Net, a transcription factor of the TCF family, as regulator of angiogenic expression. |
-
2003
- 2003-08-12 AU AU2003253440A patent/AU2003253440A1/en not_active Abandoned
- 2003-08-12 DE DE60321356T patent/DE60321356D1/de not_active Expired - Lifetime
- 2003-08-12 AT AT03795220T patent/ATE397098T1/de not_active IP Right Cessation
- 2003-08-12 EP EP03795220A patent/EP1537243B1/en not_active Expired - Lifetime
- 2003-08-12 CA CA002497132A patent/CA2497132A1/en not_active Abandoned
- 2003-08-12 WO PCT/JP2003/010257 patent/WO2004024952A1/en not_active Ceased
- 2003-08-12 JP JP2004535871A patent/JP4401295B2/ja not_active Expired - Fee Related
-
2009
- 2009-07-31 JP JP2009178542A patent/JP4942052B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005537027A5 (https=) | ||
| JP2007506426A5 (https=) | ||
| JP2009502116A5 (https=) | ||
| JP2006500948A5 (https=) | ||
| JP2006500949A5 (https=) | ||
| DK2354795T3 (en) | Methods and compositions relating to Alzheimer's disease | |
| US20200002768A1 (en) | Pulmonary hypertension biomarker | |
| JP2010042019A (ja) | マーカー遺伝子 | |
| EP2064343A1 (en) | Mammalian oocyte development competency granulosa markers and uses thereof | |
| Gaut et al. | Development of an immunoassay for the kidney-specific protein myo-inositol oxygenase, a potential biomarker of acute kidney injury | |
| JP2005110602A (ja) | アトピー性皮膚炎の疾患マーカー及びその利用 | |
| JP2008509673A5 (https=) | ||
| JP2008512984A5 (https=) | ||
| US7332294B2 (en) | CXCL10-based diagnosis and treatment of respiratory illnesses | |
| JP2006503575A5 (https=) | ||
| RU2010111116A (ru) | Pkib и naaladl2 в качестве генов-мишеней в терапии и диагностике рака предстательной железы | |
| Ouyang et al. | TATA-binding protein–TATA interaction is a key determinant of differential transcription of silkworm constitutive and silk gland-specific tRNAAla genes | |
| EP1791974A2 (en) | Biomarkers for acute graft rejection | |
| US20130102028A1 (en) | Cartilage-specific hif-2alpha transgenic mouse as an animal model for arthritis, and use thereof | |
| US20070072222A1 (en) | FABP4 as biomarker for toxic effect | |
| KR102232200B1 (ko) | 알츠하이머치매 진단 바이오마커 | |
| CN109988830A (zh) | 一种用于脓毒症标志物的lncRNA及其应用 | |
| US20100062425A1 (en) | Cat allergen | |
| KR102913281B1 (ko) | 면역억제물질 예측용 유전자 집단의 선별방법 및 이를 이용한 면역억제능 평가방법 | |
| US9228235B2 (en) | Method and kit for the classification and prognosis of chronic wounds |